Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status. (Q50899665)
Jump to navigation
Jump to search
scientific article published on 17 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status. |
scientific article published on 17 June 2013 |
Statements
Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status. (English)
1 reference
Louis P Garrison
1 reference
Joseph B Babigumira
1 reference
Edith A Perez
1 reference
Deepa Lalla
1 reference
Melissa Brammer
1 reference
Bruce Wang
1 reference
17 June 2013
1 reference
1 reference
119
1 reference
17
1 reference
3113-3122
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference